Back to Results
First PageMeta Content
Clinical research / Olanzapine / Office of Criminal Investigations / Food and Drug Administration / Off-label use / Eli Lilly / Eli Lilly controversies / James Gottstein / Eli Lilly and Company / Pharmaceutical sciences / Medicine


IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA UNITED STATES OF AMERICA v.
Add to Reading List

Document Date: 2009-01-26 16:00:47

Open Document

File Size: 2,45 MB

Share Result on Facebook

Company

Eli Lilly / ELI LILLY AND COMPANY / Lilly / EH Lilly / United States Medicaid Trust Funds / /

Country

United States / /

Currency

USD / /

Event

Business Partnership / FDA Phase / Judicial Event / /

IndustryTerm

treatment of this disease / treatment of psychotic and behavioral symptoms / pharmaceutical manufacturer / federal forfeiture law / food / treatment of behavioral and psychological symptoms / treatment of Alzheimer's / /

MedicalCondition

dementia / arthritis / Alzheimer's dementia / psychotic disorders / obesity / schizophrenia / disease / I Disorder / Alzheimer's / hyperglycemia / diabetes / seizure / depression / generalized sleep disorder / disorders / Bipolar Disorder / /

Organization

office of Inspector General / Food and Drug Administration / UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA UNITED STATES OF AMERICA / United States Attorney's office for the Eastern District of Pennsylvania / United States Department of Justice / office of Consumer Litigation / Criminal Division / Congress / office of Criminal Investigations / US Federal Reserve / Department of Health and Human Services / Defense Criminal Investigative Service / Civil Division / /

Person

Zyprexa / /

Position

care physician / Office ofthe United States Attorney / counsel / the United States Attorney / physician sales representatives / United States Attorney / /

Product

Evista / Oraflex / olanzapine / Zyprexa / Food / /

ProvinceOrState

District of Columbia / Pennsylvania / /

SocialTag